Skip to main content
SpringerLink
Log in

Hypericum perforatum versus fluoxetine in the treatment of mild to moderate depression

  • Published:
Advances in Therapy Aims and scope Submit manuscript

Abstract

In a randomized, controlled, double-blind trial, 70 patients (mean age, 49.7 years) suffering from mild to moderate depression received one tablet of either St. John’s Wort (Hypericum perforatum) extract (Calmigen®) or fluoxetine hydrochloride (Prozac®) twice a day for 6 weeks. Efficacy was determined according to the 17-item Hamilton Rating Scale for Depression (HAMD), the von Zerssen depression scale (DS), Clinical Global Impression (CGI), and patients’ overall evaluation. Significant decreases (P<.001) of 50% in theHypericum group and 58% in the fluoxetine group in the HAMD score and of 42% and 52% on the DS spoke to the efficacy of both medications. TheHypericum extract achieved 83% of the efficacy of fluoxetine on the HAMD and 78% on the DS. Assessments by physicians (CGI) and patients indicated considerable improvement with no between-treatment differences. Of the 9 dropouts (13%), 2 in theHypericum group and 2 in the fluoxetine group were due to adverse reactions. Safety evaluations demonstrated only minor changes. TheHypericum preparation tested in this study is therapeutically equivalent to fluoxetine and is therefore a rational alternative to synthetic antidepressants.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Harrer G.Hypericum: Pflanzliches Antidepressivum für Nervenarzt und Hausarzt.Nervenheilk. 1991;10:3.

    Google Scholar 

  2. Stein M. Gegen Depressionen ist ein Kraut gewachsen.Dtsch Apoth Ztg. 1995;135:4416–4417.

    Google Scholar 

  3. Faust V. Psychotrope phytopharmaka—Möglichkeiten und Grenzen.Select/Med Akt. 1996;29:20.

    Google Scholar 

  4. Sommer H. Besserung psychovegetativer Beschwerden durch Hypericum im Rahmen einer multizentrischen Doppelblindstudie.Nervenheilk. 1991;10:308–310.

    Google Scholar 

  5. International Classification of Diseases. 10th ed. Geneva: WHO; 1991.

  6. Schakau D, Hiller K-O, Schultz-Zehden W, Teschner F. Nutzen/Risiko-Profil von Johanniskrautextrakt.Psychopharmakotherapie. 1996;3:116–122.

    Google Scholar 

  7. Diagnostic and Statistical Manual of Mental Disorders. 3rd ed, rev. Washington, DC: American Psychiatric Association; 1982.

  8. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1995.

  9. Hippius H. St. John’s wort (Hypericum perforatum)—A herbal antidepressant.Curr Med Res Opin. 1998;14:171–184.

    Article  PubMed  CAS  Google Scholar 

  10. Albrecht M, Hübner W-D, Podzuweit H, Schmidt U. Johanniskraut-Extrakt zur Behandlung der Depression.Kassenarzt. 1994;41:45–54.

    Google Scholar 

  11. Borchers HG. Ist Phytotherapie eine sinnvolle Alternative bei der Behandlung der Depression?Schweiz Z Ganzheitsmed. 1994;3:116–117.

    Google Scholar 

  12. Becker SR. Das Johanniskraut (Hypericum perforatum)—Antidepressivum aus der Natur.Schweiz Z Ganzheitsmed. 1994;2:92–94.

    Google Scholar 

  13. Gaster B, Holroyd J. St John’s wort for depression—A systematic review.Arch Intern Med. 2000; 160:152–156.

    Article  PubMed  CAS  Google Scholar 

  14. Drug Commission (Arzneimittelkommission). Vorinformation: Johanniskraut-haltige Humanarzneimittel zur innerlichen Anwendung.Pharmazeut Ztg. 2000;145/14:1077, 1153–1154.

    Google Scholar 

  15. Gruenwald J. St John’s wort—The international debate.Nutraceut World. 2001;6:26–27.

    Google Scholar 

  16. Müller WE, Schäfer C, Rolli M, Wonnemann R. Effects ofHypericum extract Li 160 on neurotransmitter uptake systems and β-adrenergic receptor density.Phytomedicine. 1996;Suppl 1:100.

    Google Scholar 

  17. Harrer G. Die Angst vor dem “Psychohammer.”Therapiewoche. 1991;41:3092–3098.

    Google Scholar 

  18. Saller R, Reichling J, Kristof O. Phytotherapie—Behandlung ohne Nebenwirkungen?Dtsch Med Wochenschr. 1998;123:58–52.

    PubMed  CAS  Google Scholar 

  19. Habs M, Honold E. Der psychoaktive Spezialextrakt WS 1490 aus dem Wurzelstock vonPiper methysticum (kava-kava)—ein Report.Forsch Komplementärmed. 1994;1:208–215.

    Google Scholar 

  20. Beaubrun G, Gray GE. A review of herbal medicines for psychiatric disorders.Psychiatr Serv. 2000;51/9:1130–1134.

    Article  PubMed  CAS  Google Scholar 

  21. Schmidt U, Harrer G, Kuhn U, Biller A. Äquivalenzvergleich Johanniskrautextrakt LoHyp-57 versus Fluoxetin-HCL. Presented at the ESCOP Conference; October 1998; London, England.

  22. Schrader E. Equivalence of St John’s Wort extract (Ze 117) and fluoxetine: a randomised, controlled study in mild-moderate depression.Int Clin Psychopharmacol. 2000;15:61–68.

    Article  PubMed  CAS  Google Scholar 

  23. Schrader E, Meier B, Brattström A.Hypericum treatment of mild-moderate depression in a placebo-controlled study. A prospective, double-blind, randomised, multicentre study.Hum Psychopharmacol. 1998;13:163–169.

    Article  Google Scholar 

  24. Woelk H. Comparison of St John’s Wort and imipramine for treating depression: a randomised controlled trial.BMJ. 2000;321:536–539.

    Article  PubMed  CAS  Google Scholar 

  25. Halama P. Wirksamkeit des Johanniskrautextraktes Li 160 bei depressiver Verstimmung.Nervenheilk. 1991;10:305–307.

    Google Scholar 

  26. Harrer G, Sommer H. Therapie leichter/mittelschwerer Depressionen mitHypericum.Münch Med Wochenschr. 1993;135:305–309.

    Google Scholar 

  27. Lehrl S, Willemsen A, Papp R, Woelk H. Ergebnisse von Messungen der kognitiven Leistungsfähigkeit bei Patienten unter der Therapie mit Johanniskrautextrakt.Nervenheilk. 1993;12:281–284.

    Google Scholar 

  28. Reh C, Laux P, Schenk N.Hypericum-Extrakt bei Depressionen—eine wirksame Alternative.Therapiewoche. 1992;42:1576–1581.

    Google Scholar 

  29. Volz HP, Laux P. Potential treatment for subthreshold and mild depression: a comparison of St. John’s Wort extracts and fluoxetine.Compr Psychiatry. 2000;41:133–137.

    Article  PubMed  CAS  Google Scholar 

  30. Maisenbacher H-J, Kuhn U. Therapie von Depressionen in der Praxis—Ergebnisse einer Anwendungsbeobachtung mit Herba Hyperici.Naturamed. 1992;7:394–399.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Frederiksberg, Denmark

    Kirsten Behnke M.D.

  2. Rødovre, Denmark

    Gert Saaby Jensen M.D.

  3. PhytoPharm Consulting, Institute for Phytopharmaceuticals, Berlin, Germany

    Hans-Joachim Graubaum Ph.D. & Joerg Gruenwald Ph.D.

Authors
  1. Kirsten Behnke M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gert Saaby Jensen M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hans-Joachim Graubaum Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Joerg Gruenwald Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Behnke, K., Jensen, G.S., Graubaum, HJ. et al. Hypericum perforatum versus fluoxetine in the treatment of mild to moderate depression. Adv Therapy 19, 43–52 (2002). https://doi.org/10.1007/BF02850017

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02850017

Keywords

Search

Navigation